{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:57:40Z","timestamp":1763017060825},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/bmt.2010.177","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T10:51:10Z","timestamp":1283770270000},"page":"690-701","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution"],"prefix":"10.1038","volume":"46","author":[{"given":"R","family":"Martino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kerguelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Valc\u00e1rcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Fachini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Pi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Briones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,6]]},"reference":[{"key":"BFbmt2010177_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143\u20131238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010177_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(00)02137-1","volume":"355","author":"F Frassoni","year":"2000","unstructured":"Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393\u20131398.","journal-title":"Lancet"},{"key":"BFbmt2010177_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005; 36: 757\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","volume":"94","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465\u20131470.","journal-title":"Blood"},{"key":"BFbmt2010177_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010177_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2141.2001.03153.x","volume":"115","author":"R Martino","year":"2001","unstructured":"Martino R, Caballero MD, Canals C, Simon JA, Solano C, Urbano-Ispizua A et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 2001; 115: 653\u2013659.","journal-title":"Br J Haematol"},{"key":"BFbmt2010177_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.bmt.1705879","volume":"41","author":"R Martino","year":"2008","unstructured":"Martino R, Valcarcel D, Brunet S, Sureda A, Sierra J . Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2008; 41: 33\u201338.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR8","first-page":"1075","volume":"86","author":"R Martino","year":"2001","unstructured":"Martino R, Rovira M, Carreras E, Solano C, Jorge S, De La RJ et al. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation. Haematologica 2001; 86: 1075\u20131086.","journal-title":"Haematologica"},{"key":"BFbmt2010177_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood.V97.2.383","volume":"97","author":"A Urbano-Ispizua","year":"2001","unstructured":"Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la RJ, Brunet S et al. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood 2001; 97: 383\u2013387.","journal-title":"Blood"},{"key":"BFbmt2010177_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1086\/426447","volume":"40","author":"R Martino","year":"2005","unstructured":"Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40: 67\u201378.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2010177_CR11","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt2010177_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.bmt.1703150","volume":"28","author":"R Martino","year":"2001","unstructured":"Martino R, Caballero MD, Canals C, San MJ, Sierra J, Rovira M et al. Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 341\u2013347.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR13","first-page":"1238","volume":"89","author":"A Bacigalupo","year":"2004","unstructured":"Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89: 1238\u20131247.","journal-title":"Haematologica"},{"key":"BFbmt2010177_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1600-0609.2009.01249.x","volume":"83","author":"N Cantoni","year":"2009","unstructured":"Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D et al. Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality. Eur J Haematol 2009; 83: 130\u2013138.","journal-title":"Eur J Haematol"},{"key":"BFbmt2010177_CR15","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1002\/cncr.24531","volume":"115","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de WT et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009; 115: 4715\u20134726.","journal-title":"Cancer"},{"key":"BFbmt2010177_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","volume":"113","author":"G Gahrton","year":"2001","unstructured":"Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Bjorkstrand B et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983\u201393 and 1994\u20138 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209\u2013216.","journal-title":"Br J Haematol"},{"key":"BFbmt2010177_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/sj.bmt.1705118","volume":"36","author":"NM Blijlevens","year":"2005","unstructured":"Blijlevens NM, Donnelly JP, DePauw BE . Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2005; 36: 703\u2013707.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/bmt.2008.270","volume":"43","author":"V van d","year":"2009","unstructured":"van d V, Blijlevens NM, Feuth T, Donnelly JP . Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant 2009; 43: 55\u201360.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1086\/317471","volume":"31","author":"R Martino","year":"2000","unstructured":"Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188\u20131195.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2010177_CR20","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","volume":"107","author":"M Boeckh","year":"2006","unstructured":"Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA . Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study. Blood 2006; 107: 1800\u20131805.","journal-title":"Blood"},{"key":"BFbmt2010177_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbmt.2006.03.007","volume":"12","author":"R Parody","year":"2006","unstructured":"Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la CR et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734\u2013748.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010177_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/bmt.2009.149","volume":"45","author":"A Safdar","year":"2010","unstructured":"Safdar A, Rodriguez GH, Mihu CN, Mora-Ramos L, Mulanovich V, Chemaly RF et al. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention. Bone Marrow Transplant 2010; 45: 339\u2013347.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010177_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","volume":"116","author":"R Martino","year":"2002","unstructured":"Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475\u2013482.","journal-title":"Br J Haematol"},{"key":"BFbmt2010177_CR24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1182\/blood-2002-11-3503","volume":"102","author":"JA Perez-Simon","year":"2003","unstructured":"Perez-Simon JA, ez-Campelo M, Martino R, Sureda A, Caballero D, Canizo C et al. Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. Blood 2003; 102: 1108\u20131113.","journal-title":"Blood"},{"key":"BFbmt2010177_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2402977","volume":"17","author":"A Urbano-Ispizua","year":"2003","unstructured":"Urbano-Ispizua A . High stem cell dose in haemopoietic transplantation: is it always beneficial? Leukemia 2003; 17: 1467\u20131469.","journal-title":"Leukemia"},{"key":"BFbmt2010177_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2402909","volume":"17","author":"M Mohty","year":"2003","unstructured":"Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 2003; 17: 869\u2013875.","journal-title":"Leukemia"},{"key":"BFbmt2010177_CR27","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221\u20133227.","journal-title":"Blood"},{"key":"BFbmt2010177_CR28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1080\/10428190903085944","volume":"50","author":"J Mehta","year":"2009","unstructured":"Mehta J, Frankfurt O, Altman J, Evens A, Tallman M, Gordon L et al. Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2009; 50: 1434\u20131441.","journal-title":"Leuk Lymphoma"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:33:22Z","timestamp":1648042402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFbmt2010177"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.177","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,6]]},"assertion":[{"value":"12 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}